Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 50 and 80 years old
- You have been diagnosed with mild cognitive impairment (early-stage memory or thinking difficulties) based on a specific set of medical guidelines known as Peterson's criteria
- You have noticed problems with your memory or thinking yourself, but your score on a standard memory test (the Hong Kong version of the Montreal Cognitive Assessment) came back normal
- You are able to speak and read Chinese
- You have good enough vision and hearing to complete a cognitive (thinking and memory) test
- You have either moderate-to-severe sleep apnoea (a condition where breathing repeatedly stops during sleep) or no sleep apnoea at all, confirmed by a sleep study — these participants may be invited for a special brain scan
Who may not be able to join:
- You have been diagnosed with a psychiatric (mental health) condition, such as major depression, whether or not you are taking medication for it
- You have another known medical reason for your memory or thinking difficulties, such as stroke-related cognitive problems, a brain tumour, Parkinson's disease, certain types of dementia, or other specific brain or nervous system conditions (confirm with trial site for the full list)
- You are currently receiving active treatment for cancer
- You have a medical reason why you cannot safely have a PET-CT or MRI brain scan, such as a pacemaker or metal implants (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mary SM Ip, MD, School of Clinical Medicine, The University of Hong Kong
Phone: 2255 5885
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in neurocognitive function (ADAS Cog); Cerebral amyloid update in moderate to severe OSA and no to mild OSA
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.